We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Policy

Connecticut Governor Signs Bill to Give Patients Access to MDMA and Psilocybin Therapy

By Leo Bear-McGuinness

Published: May 10, 2022   

Complete the form below and we will email you a PDF version of "Connecticut Governor Signs Bill to Give Patients Access to MDMA and Psilocybin Therapy"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Connecticut Governor Signs Bill to Give Patients Access to MDMA and Psilocybin Therapy

Connecticut Governor Ned Lamont signed a budget bill on Monday, May 9th, that included provisions to give patients access to psychedelic-assisted treatments.

Among the bill’s myriad of policy areas, from childcare to environmental protection, the legislation vowed to establish “a psychedelic-assisted therapy pilot program to provide qualified patients with the funding necessary to receive MDMA-assisted or psilocybin-assisted therapy as part of an expanded access program approved by the federal Food and Drug Administration”.

A fund will also be created to issue grants to qualified patients so they can afford the psychedelic-assisted therapy.

As a requirement for treatment, the qualified patients must reside in the state and be either a veteran, a retired first responder or a direct healthcare worker.

The bill also legislates that a new Connecticut Psychedelic Treatment Advisory Board be established by July to oversee the new treatments and patient processing.

The bill’s passing follows the formation of a psychedelic task force last year, which was established to study the feasibility of psychedelic-assisted therapy and make recommendations on whether it should be permitted in the state. It handed in its findings and recommendations this January.

 

Like what you just read? You can find similar content on the topic tags shown below.

Policy Science & Health Psychedelics

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement